These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 8105046)
1. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers. Delahunt B; Bethwaite PB; Nacey JN; Ribas JL J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors]. Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387 [TBL] [Abstract][Full Text] [Related]
4. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma. Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714 [TBL] [Abstract][Full Text] [Related]
5. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532 [TBL] [Abstract][Full Text] [Related]
6. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis. Cheville JC; Terrell RB; Cohen MB Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516 [TBL] [Abstract][Full Text] [Related]
7. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content]. Nakano S; Kawamura J Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of the prognostic value of nuclear grade and silver-binding nucleolar organizer region in renal cell carcinomas. Yang AH; Wang TY; Liu HC J Pathol; 1992 Feb; 166(2):157-61. PubMed ID: 1560316 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)]. Ebelt J; Neid M; Tannapfel A; Witzigmann H; Hauss J; Köckerling F; Wittekind C Zentralbl Chir; 2000; 125(7):597-601. PubMed ID: 10960968 [TBL] [Abstract][Full Text] [Related]
10. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer]. Zhao T; Zhang YL; Li CD Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415 [TBL] [Abstract][Full Text] [Related]
11. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [TBL] [Abstract][Full Text] [Related]
12. Nucleolar organizer regions and prognosis in renal cell carcinoma. Delahunt B; Ribas JL; Nacey JN; Bethwaite PB J Pathol; 1991 Jan; 163(1):31-7. PubMed ID: 2002422 [TBL] [Abstract][Full Text] [Related]
13. Assessment of proliferative activity in Wilms' tumour. Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823 [TBL] [Abstract][Full Text] [Related]
14. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas. Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623 [TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F; Hiroi M; Yamane T; Hara H Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma. Tannapfel A; Geissler F; Köckerling F; Katalinic A; Hauss J; Wittekind C J Pathol; 1999 Mar; 187(4):439-45. PubMed ID: 10398104 [TBL] [Abstract][Full Text] [Related]
17. Proliferative activity is a significant prognostic factor in male breast carcinoma. Pich A; Margaria E; Chiusa L Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830 [TBL] [Abstract][Full Text] [Related]
18. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002). Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784 [TBL] [Abstract][Full Text] [Related]
19. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma. Khurana KK; Truong LD; Verani RR Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084 [TBL] [Abstract][Full Text] [Related]